Sign in

CIK 0001831828

  • Large accelerated filer

Vera Therapeutics, Inc.

Sign in to watch
Ticker
VERA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
812744449
Phone
+1 650-770-0077
Business address
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE, CA, 94005
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 30,837 shares at an average $42.30 ($1,304,435)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Open-market sale SVP, FINANCE, CHIEF ACCT OFFCR sold 5,714 shares at $40.00 ($228,560)
  14. 4 Open-market sale CHIEF FINANCIAL OFFICER sold 118,477 shares at an average $39.58 ($4,689,722)
  15. 4 Gift CHIEF FINANCIAL OFFICER gave 16,541 shares (gift)
  16. 4 Open-market sale Director sold 834,459 shares at an average $40.86 ($34,099,583)
  17. 4 Open-market buy Director bought 161,290 shares at $31.00 ($4,999,990)
  18. 4 Grant or award PRESIDENT AND CEO acquired 78,750 shares (grant or award)
  19. 4 Grant or award SVP, FINANCE, CHIEF ACCT OFFCR acquired 21,875 shares (grant or award)
  20. 4 Grant or award CHIEF FINANCIAL OFFICER acquired 26,250 shares (grant or award)

Page 5 of 12 · 230 filings